CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Organigram

Ivan A. Salazar, Plant Packaging & Sanitation Manager

Cannabis and Biotech: Today and Tomorrow

Ivan A. Salazar

Ivan A Salazar

The Cannabis industry has been growing rapidly, with significant advancements in biotechnology and a trend toward legalization in the U.S., Europe, and other regions. Here is an overview of the current trends and prospects in terms of commercialization and research to satisfy both medical and recreational demand:


Current Trends


Growth Trajectory: The Canadian cannabis market is projected to reach $7.2 billion in 2027, driven by significant demand in provinces like Ontario and Alberta.


Product Preferences: Flower and pre-rolls are still the most popular products among Canadian cannabis consumers. Innovations in this segment, like infused pre-rolls and pre-milled flower, are gaining traction.


Consumer Behavior: The normalization of cannabis use in Canada is clear, especially post-pandemic. Usage occasions are expanding to include everyday meals and social gatherings like dinner parties, showing cannabis’s increasing integration into daily life1.


Technological Advancements: Innovative technologies, including artificial intelligence (AI), Internet of Things (IoT), and data analytics, are revolutionizing cultivation practices, leading to increased efficiency and optimized yields.


Prospects


Market Growth: The global cannabis market is expected to grow significantly by 2024, fueled by new product offerings, technological advancements, and groundbreaking research. 


The U.S. cannabis market is projected to grow significantly, with retail cannabis sales predicted to reach $53.5 billion by 2027.


Product Innovation: The trend toward personalized cannabis products is expected to gain traction as consumers become more educated and discerning.


Legislative Predictions: Many other states are expected to legalize recreational cannabis in 2024.


Technological Advancements: Blockchain and AI will revolutionize supply chain management and compliance tracking.


In terms of research, the rapidly growing cannabis industry has given rise to biotech companies focusing on innovative technologies for cannabis cultivation, as well as the development of cannabis-based medical therapies for an array of diseases and ailments.


It is important to note that while the industry is growing rapidly, it also faces challenges such as regulatory hurdles, market volatility, and competition from the illicit market. Despite these challenges, the future of the cannabis industry looks promising, with continuous growth, innovation, and increasing acceptance globally.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://life-science-consulting-canada.lifesciencesreview.com/leadership-perspective/cannabis-and-biotech-today-and-tomorrow-nwid-1887.html